Pharmaron Beijing
SZSE:300759
¥ 30,38
+ ¥2,40 (8,58%)
30,38 ¥
+¥2,40 (8,58%)
End-of-day quote: 04/01/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥0,63
Earnings Per Share
¥6,95
Revenue Per Share
34,09%
Gross Margin %
¥47,19 B
Market Cap
¥4,38 B
Long-Term Debt
Earnings Per Share
¥0,63
Revenue Per Share
¥6,95
Gross Margin %
34,09%
Market Cap
¥47,19 B
Long-Term Debt
¥4,38 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2017
EPS Earnings Per Share ¥0,63 ¥0,85 ¥0,80 ¥0,74 ¥0,45 ¥0,34 ¥0,17
Earnings Earnings ¥1,11B ¥1,52B ¥1,43B ¥1,32B ¥804,32M ¥607,71M ¥225,93M
RPS Revenue Per Share ¥6,95 ¥6,46 ¥5,75 ¥4,17 ¥2,87 ¥2,10 ¥1,73
Revenue Revenue ¥12,28B ¥11,54B ¥10,27B ¥7,44B ¥5,13B ¥3,76B ¥2,29B
OCF Operating Cash Flow ¥2,58B ¥2,75B ¥2,14B ¥2,06B ¥1,65B ¥938,59M ¥0,00M
FCF Free Cash Flow ¥539,34M ¥-682,27M ¥-803,89M ¥-33,17M ¥335,98M ¥187,42M ¥0,00M
OM Operating Margin 14,01% 14,64% 16,23% 19,45% 19,87% 17,70% 0,00%
GM % Gross Margin % 34,09% 35,67% 36,67% 35,95% 37,38% 35,49% 0,00%
FCFS Free Cash Flow Per Share ¥0,30 ¥-0,06 ¥-0,46 ¥-0,02 ¥0,42 ¥0,28 ¥0,00
LT Debt Long-Term Debt ¥4,38B ¥8,20B ¥4,45B ¥4,42B ¥394,81M ¥542,03M ¥829,47M
Sha. Stocks 1.766,1M 1.787,39M 1.786,84M 1.786,9M 1.787,37M 1.787,37M 1.328,99M
×